Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema

International Ophthalmology

Volumn 27, Issue 5, 2007, Pages 299-306

  Batıoğlu, Figen ^a,b   Özmert, Emin ^a   Parmak, Neslihan ^a   Çelik, Selcen ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Meric Sokak   (Turkey)

Author keywords

Diabetic macular edema; Intravitreal triamcinolone acetonide; Optical coherence tomography

Indexed keywords

ANTIGLAUCOMA AGENT; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CATARACT; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; FEMALE; FRIEDMAN TEST; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; RETINA FOVEA; SIDE EFFECT; TREATMENT FAILURE; VISUAL ACUITY;

EID: 34548509483     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-007-9072-7     Document Type: Article

References (24)

1. Ferris FL, Patz A (1984) Macular edema. A complication of diabetic retinopathy. Surv Ophthalmol 28:452-461
2. Early Treatment Diabetic Retinopathy Study Research Group (1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103:1796-1806
3. Lee CM, Olk RJ (1991) Modified grid laser photocoagulation for diffuse diabetic macular edema: Long-term visual results. Ophthalmology 98:1594-1602
4. Martidis A, Duker JS, Greenberg PB, et al (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109(5):920-927
5. Ip MS, Kumar KS (2002) Intravitreous triamcinolone acetonide as a treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol 120:1217-1219
6. Antcliff RJ, Spalton DJ, Stanford MR, et al (2001) Intravitreal triamcinolone for uveitic cystoid macular edema: An optical coherence tomography study. Ophthalmology 108:765-772
7. Benhamou B, Massin P., Haouchine B, et al (2003) Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 135:246-249
8. Tano Y, Chandler D, Machemer R (1980) Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 90:810-816
9. Danis RP, Bingaman DP, Yang Y, Ladd B (1996) Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 103:2099-2104
10. Danis RP, Ciulla TA, Pratt LM, Anliker W (2000) Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20:244-250
11. Massin P, Audren F, Haouchine B, et al (2004) Intravitreal triamcinolone acetonide for diabetic diffuse macular edema. Preliminary results of a prospective controlled trial. Ophthalmology 111:218-225
12. Blodi BA, Paluska SA (1997) Cataract after vitrectomy in young patients. Ophthalmology 104:1092-1095
13. Sidney S, Castellan J (1988) Nonparametric statistics for the behavioral sciences. McGraw-Hill, New York, pp 174-183, chapt 7
14. Graham RO, Peyman GA (1974) Intravitreal injection of dexamethasone: treatment of experimentally induced endophthalmitis. Arch Ophthalmol 92:149-154
15. Wilson CA, Berkowitz BA, Sato Y, et al (1992) Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 110:1155-1159
16. Bresnick GH (1986) Diabetic macular edema: A review. Ophthalmology 93:989-997
17. Jonas JB, Kreissig I, Sofker A, Degenring RF (2003) Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57-61
18. Larsson J, Zhu M, Sutter F, Gillies MC (2005) Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Am J Ophthalmol 139:802-806
19. Jonas JB, Kreissig I, Degenring RF (2003) Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 87:24-27
20. Jonas JB, Degengring RF, Kamppeter BA, Kreissig I, Akkoyun Ä, (2004) Duration of the effect of intravitreal triamcinolone acetonide as treatment of diffuse diabetic macular edema. Am J Ophthalmol 138:158-160
21. Bucala R, Gallati M, Manabe S, Cother E, Cerami A (1985) Glucocorticoid-lens protein adducts in experimentally induced steroid cataracts. Exp Eye Res 40:853-863
22. Danis RP, Ciulla TA, Pratt LM, Anliker W (2000) Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20:244-250
23. Gillies MC, Simpson JM, Billson TA et al (2004) Safety of an intravitreal injection of triamcinolone. Results from a randomized clinical trial. Arch Ophthalmol 133:336-340
24. Çekiç O, Chang S, Tseng JJ et al (2005) Cataract progression after intravitreal triamcinolone injection. Am J Ophthalmol 139:993-998